Results 101 to 110 of about 9,624 (222)

A case of laryngeal leishmaniasis presenting as hoarseness in an Ethiopian patient: a case report

open access: yesJournal of Medical Case Reports
Background Leishmaniasis is a zoonotic disease caused by unicellular protozoa of the Leishmania genus. The infection can spread through zoonotic or anthroponotic transmission, depending on the species, with the phlebotomine sandfly serving as the primary
Mohammedsefa Arusi Dari   +4 more
doaj   +1 more source

Leishmaniasis: A review of the disease and the debate over the origin and dispersal of the causaitive parasite Leishmania [PDF]

open access: yes, 2009
The vector borne disease Leishmaniasis, caused by the Leishmania parasite, is estimated to affect the lives of 12 million people. Manifesting itself into three different clinical forms that center on disfiguring sores and enlargement of several organs ...
MacMorris-Adix, Molly
core   +1 more source

Clinical, laboratory, and therapeutic characteristics of American tegumentary leishmaniasis in the 15 th State Health Division, Northwest Paraná State, Southern Brazil

open access: yesRevista da Sociedade Brasileira de Medicina Tropical
INTRODUCTION American tegumentary leishmaniasis (ATL) is an endemic disease in many regions of Brazil; however, only few reports on the actual epidemiological conditions are available.
Priscila Wolf Nassif   +7 more
doaj   +1 more source

Pupal surveys for Aedes aegypti surveillance and potential targeted control in residential areas of Mérida, México.

open access: yes, 2008
A mosquito larval-pupal survey was conducted in 1,160 households of the Mexican city of Mérida during the rainy season of 2003 to determine their differential productivity for Aedes aegypti.
Che-Medoza, Azael   +6 more
core   +1 more source

Preface. Leishmaniasis. Global impact on health [PDF]

open access: yes, 2017
Over the last decade, public authorities from all parts of the world have expressed their growing concern about leishmaniasis being a serious threat to health. This increased awareness occurred partly as a result of serious outbreaks which were reported,
de Raadt, P.
core  

Lupoid mucocutaneous leishmaniasis [PDF]

open access: yesDermatology Review, 2018
Tizita Yosef   +2 more
openaire   +1 more source

A Review of the Progress in the Development of Leishmaniasis Vaccines [PDF]

open access: yesJournal of Ardabil University of Medical Sciences
Leishmaniasis is a parasitic infectious disease that accounts for approximately one million new cases annually. The treatment of this disease is complex and costly, particularly in developing countries.
Narges Khaghanzadeh   +2 more
doaj  

American Tegumentary Leishmaniasis: Is Antimonial Treatment Outcome Related to Parasite Drug Susceptibility? [PDF]

open access: yes, 2017
BackgroundAntimonials are the first drug of choice for the treatment of American tegumentary leishmaniasis (ATL); however, their efficacy is not predictable, and this may be linked to parasite drug resistance.
Adui, Vanessa   +11 more
core  

Anti-leishmania igA immunoenzymatic assay in mucocutaneous leishmaniasis (Preliminary report) Ensaio Imunoenzimático de IgA Anti-Leishmânia na Leishmaniose mucocutânea (Nota Prévia)

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1984
The Authors describe an anti-Leishmania IgA-ELISA assay in mucocutaneous leishmaniasis. Increased titers were found in leishmaniasis patients, mainly in the first and second year of infection and in deep mycoses patients showing either mucosal ...
M. Carolina S. Guimarães   +5 more
doaj  

Home - About - Disclaimer - Privacy